| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.8041 | 31 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.6355 | 25 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.1364 | 10 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.0312 | 18 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.2524 | 14 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.285 | 29 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 40.4366 | 8 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.993 | 9 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 38.5868 | 3 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.2503 | 28 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 39.857 | 6 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.6629 | 50 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 40.6643 | 8 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.6103 | 39 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.5112 | 39 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.4001 | 29 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.5551 | 25 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.4785 | 11 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.393 | 29 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.8226 | 12 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 42.4087 | 15 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.633 | 12 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.1399 | 4 |